Merck & Co Inc (NYSE:MRK)

58.54
Delayed Data
As of Feb 27
 -0.42 / -0.71%
Today’s Change
52.49
Today|||52-Week Range
63.62
+3.08%
Year-to-Date
Fast Money Picks For March 2
Mar 01 / Benzinga
What's in Store for Endocyte (ECYT) this Earnings Season? - Analyst Blog
Feb 20 / Zacks.com
Billionaire George Soros Just Dumped These 3 Dividend Stocks
Mar 01 / MotleyFool.com
$20 Billion Market: Whatbs the Best Stock to Buy?
Feb 20 / MotleyFool.com
This Billionaire CEO Just Made Another Biotech Acquisition -- and Hardly Anyone Notic...
Feb 28 / MotleyFool.com
Hospira Launches Inflectra, Remicade Biosimilar, in Europe - Analyst Blog
Feb 17 / Zacks.com
Which Cancer Immunotherapy Will Be the Most Successful?
Feb 28 / MotleyFool.com
Deal-Hungry Pfizer Won't Stop With Hospira; Who Could Be Next?
Feb 16 / MotleyFool.com
Dow 30 Stock Roundup: Home Depot Beats, Chevron Issues $6B in Bonds - Analyst Blog
Feb 27 / Zacks.com
Could This Be The Biggest Advance in Hepatitis C since Gilead Sciences' Sovaldi?
Feb 16 / MotleyFool.com
Dow Jones (DJIA) Today: Merck (MRK) Lower
Feb 27 / TheStreet.com
Investor flows reignite corporate bond issuance
Feb 06 / FT.com
Bayer Q4 Net Income Down Y/Y, Provides 2015 Outlook - Analyst Blog
Feb 27 / Zacks.com
Merck defends children's vaccines after measles outbreak
Feb 04 / FT.com
Dow Jones (DJIA) Today: Merck (MRK) Leads The Day Higher, Intel (INTC) Lags
Feb 26 / TheStreet.com
Stocks: 4 things to know before the open
Feb 04 / CNNMoney.com
Heavy News Day For Several Biotech Stocks
Feb 25 / Benzinga
Gilead to cut price of $1,000-a-day pill
Feb 03 / FT.com
The 3 Biggest Disappointments This Earnings Season
Feb 25 / MotleyFool.com
Offshore corporate cash piles at risk from Obama tax plan
Feb 02 / CNNMoney.com
Hospira and Celltrion launch biosimilars
Feb 24 / FT.com
Two military healthcare workers flown back to UK on Ebola fears
Feb 02 / FT.com
Merck Strikes Deal with NGM to Develop Novel Biologics - Analyst Blog
Feb 24 / Zacks.com
Big pharmaceuticals groups faces biosimilars challenge
Feb 02 / FT.com
Agilent-ONO Companion Diagnostics Aim - Analyst Blog
Feb 23 / Zacks.com
Here are the drivers of future economic growth
Feb 01 / CNNMoney.com
Eli Lilly Extends Phase III Cholesterol Study by Six Months - Analyst Blog
Feb 20 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account